AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND MOHAMMAD HARIS, PH.D.Scientific Advisory Board Agreement • January 19th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations
Contract Type FiledJanuary 19th, 2023 Company IndustryAgreement made on November 22, 2022, by and between MOHAMMAD HARIS (“Scientific Advisory Board Member” also referred to as ”SAB Member ”), a natural person whose address is___________, and Regen BioPharma, Inc. (“Company”), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. SAB Member and Company may be referred to individually as “Party” and collectively as “Parties”.
Consultant's Fee AgreementConsultant's Fee Agreement • January 19th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations
Contract Type FiledJanuary 19th, 2023 Company IndustryAGREEMENT ("Agreement") made this 20 day of October 2022, by and between Michael Dawald, (a private individual) hereinafter referred to as the "Consultant", and Regen BioPharma, Inc.(a Nevada corporation whose Series A Preferred shares currently trade over the OTC Pink Market under the symbol RG3PP) , hereinafter referred to as the "Company". Company and Consultant may be collectively referred to as "Parties" and individually referred to as "Party".